In fact, for Foxp3 + TILs, there are some conflicting results regarding prognostic significance between patients with colorectal and head and neck cancer and those with melanoma, breast, ovarian, and gastric cancer [11–13, 32]. This evidence concerns the gene FOXP3 and melanoma.